Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes

Overview of attention for article published in Cardiovascular Diabetology, March 2009

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Second and Third-Line Therapy for Patients With Diabetes (Optimal Use Project)

Cited by Canadian Agency for Drugs and Technologies in Health on 02 Jul 2013

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Third-Line Therapy for Patients with Type 2 Diabetes Inadequately Controlled with Metformin and a Sulfonylurea

Cited by Canadian Agency for Drugs and Technologies in Health on 10 Aug 2010

Third-Line Therapy for Patients with Type 2 Diabetes Inadequately Controlled with Metformin and a Sulfonylurea

Cited by Canadian Agency for Drugs and Technologies in Health on 09 Aug 2010

Second and Third-Line Therapy for Patients With Diabetes (Optimal Use Project)

Cited by Canadian Agency for Drugs and Technologies in Health on 30 Jul 2010

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.